| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 21 | 2026 | 731 | 3.240 |
Why?
|
| Genome, Human | 29 | 2026 | 1314 | 3.050 |
Why?
|
| Genetic Variation | 17 | 2026 | 1542 | 2.310 |
Why?
|
| Epigenomics | 8 | 2016 | 179 | 2.060 |
Why?
|
| DNA Methylation | 16 | 2023 | 1075 | 1.810 |
Why?
|
| Epigenesis, Genetic | 14 | 2021 | 756 | 1.790 |
Why?
|
| Computational Biology | 13 | 2026 | 862 | 1.640 |
Why?
|
| Gene Regulatory Networks | 6 | 2026 | 380 | 1.540 |
Why?
|
| Extracellular Vesicles | 6 | 2023 | 75 | 1.290 |
Why?
|
| Metabolomics | 3 | 2022 | 501 | 1.150 |
Why?
|
| Sequence Analysis, DNA | 20 | 2018 | 1695 | 1.130 |
Why?
|
| Genome | 13 | 2012 | 453 | 1.070 |
Why?
|
| Databases, Genetic | 13 | 2026 | 501 | 1.060 |
Why?
|
| Disease | 3 | 2018 | 122 | 0.960 |
Why?
|
| Algorithms | 8 | 2021 | 1663 | 0.930 |
Why?
|
| DNA | 13 | 2016 | 1400 | 0.900 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 2600 | 0.800 |
Why?
|
| Evolution, Molecular | 13 | 2015 | 645 | 0.740 |
Why?
|
| Information Theory | 1 | 2021 | 6 | 0.670 |
Why?
|
| Ganglia, Sensory | 1 | 2020 | 5 | 0.670 |
Why?
|
| MicroRNAs | 7 | 2020 | 889 | 0.660 |
Why?
|
| Genes, Neoplasm | 2 | 2013 | 80 | 0.650 |
Why?
|
| RNA | 5 | 2023 | 515 | 0.650 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 140 | 0.640 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 1807 | 0.610 |
Why?
|
| Chromosome Mapping | 8 | 2025 | 1046 | 0.590 |
Why?
|
| Genomic Instability | 4 | 2014 | 245 | 0.590 |
Why?
|
| Allelic Imbalance | 1 | 2018 | 11 | 0.570 |
Why?
|
| Neuroglia | 1 | 2020 | 224 | 0.570 |
Why?
|
| Dental Pulp | 1 | 2018 | 4 | 0.560 |
Why?
|
| Cell Communication | 1 | 2019 | 189 | 0.550 |
Why?
|
| Humans | 88 | 2026 | 130481 | 0.540 |
Why?
|
| Genomics | 11 | 2026 | 1613 | 0.540 |
Why?
|
| Melatonin | 1 | 2018 | 30 | 0.540 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 90 | 0.540 |
Why?
|
| Glioblastoma | 2 | 2020 | 376 | 0.530 |
Why?
|
| Quantum Theory | 1 | 2016 | 19 | 0.490 |
Why?
|
| Electrons | 1 | 2016 | 25 | 0.490 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2023 | 2825 | 0.490 |
Why?
|
| Endothelial Cells | 1 | 2020 | 521 | 0.490 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 384 | 0.480 |
Why?
|
| Hyperglycemia | 1 | 2018 | 233 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2023 | 888 | 0.470 |
Why?
|
| Adenine | 1 | 2016 | 119 | 0.460 |
Why?
|
| Macaca mulatta | 6 | 2011 | 492 | 0.460 |
Why?
|
| Mutation Rate | 2 | 2013 | 68 | 0.460 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1921 | 0.460 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2015 | 28 | 0.440 |
Why?
|
| Smoking | 2 | 2025 | 928 | 0.440 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 411 | 0.440 |
Why?
|
| Glioma | 1 | 2020 | 508 | 0.440 |
Why?
|
| Metagenomics | 2 | 2012 | 114 | 0.430 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2019 | 54 | 0.420 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 385 | 0.420 |
Why?
|
| Sequence Alignment | 5 | 2014 | 583 | 0.420 |
Why?
|
| Mutation | 8 | 2017 | 6095 | 0.400 |
Why?
|
| Chromosome Aberrations | 3 | 2011 | 574 | 0.390 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 25 | 0.390 |
Why?
|
| Oncogene Fusion | 1 | 2013 | 25 | 0.390 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 631 | 0.390 |
Why?
|
| DNA Copy Number Variations | 3 | 2013 | 1022 | 0.380 |
Why?
|
| Neoplasms | 6 | 2023 | 2966 | 0.370 |
Why?
|
| Nanoparticles | 2 | 2026 | 298 | 0.370 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 217 | 0.360 |
Why?
|
| Lipids | 2 | 2026 | 558 | 0.360 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2012 | 378 | 0.350 |
Why?
|
| CpG Islands | 9 | 2018 | 334 | 0.340 |
Why?
|
| Base Sequence | 11 | 2015 | 2737 | 0.340 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 706 | 0.330 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2010 | 296 | 0.320 |
Why?
|
| Brain | 3 | 2020 | 3180 | 0.320 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 3714 | 0.320 |
Why?
|
| Animals | 40 | 2026 | 33849 | 0.320 |
Why?
|
| Gene Dosage | 2 | 2011 | 436 | 0.310 |
Why?
|
| Chromosome Breakage | 2 | 2008 | 154 | 0.300 |
Why?
|
| Pre-Eclampsia | 2 | 2021 | 225 | 0.290 |
Why?
|
| Inflammation | 3 | 2026 | 1485 | 0.290 |
Why?
|
| Metabolome | 2 | 2021 | 324 | 0.280 |
Why?
|
| Gene Rearrangement | 4 | 2015 | 323 | 0.280 |
Why?
|
| Alleles | 5 | 2018 | 1677 | 0.270 |
Why?
|
| Chromosomes, Artificial, Bacterial | 6 | 2008 | 87 | 0.270 |
Why?
|
| Environmental Monitoring | 2 | 2025 | 101 | 0.270 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2015 | 238 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1445 | 0.260 |
Why?
|
| Metagenome | 3 | 2012 | 139 | 0.250 |
Why?
|
| Research Design | 3 | 2013 | 715 | 0.230 |
Why?
|
| Neurosurgical Procedures | 2 | 2025 | 320 | 0.230 |
Why?
|
| Hylobates | 3 | 2012 | 10 | 0.230 |
Why?
|
| Tryptophan | 2 | 2016 | 83 | 0.230 |
Why?
|
| Chironomidae | 1 | 2025 | 2 | 0.230 |
Why?
|
| Computer Simulation | 5 | 2020 | 672 | 0.230 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2025 | 36 | 0.230 |
Why?
|
| Pinealoma | 1 | 2025 | 20 | 0.230 |
Why?
|
| Pineal Gland | 1 | 2025 | 21 | 0.230 |
Why?
|
| Periodontitis | 1 | 2025 | 19 | 0.230 |
Why?
|
| Metal Nanoparticles | 2 | 2016 | 55 | 0.220 |
Why?
|
| Microsurgery | 1 | 2025 | 65 | 0.220 |
Why?
|
| Endosomes | 1 | 2025 | 71 | 0.220 |
Why?
|
| Hydroxychloroquine | 1 | 2024 | 19 | 0.220 |
Why?
|
| Diphosphonates | 1 | 2024 | 40 | 0.210 |
Why?
|
| Bone Resorption | 1 | 2024 | 52 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 2011 | 0.210 |
Why?
|
| Workflow | 1 | 2025 | 143 | 0.210 |
Why?
|
| Data Mining | 2 | 2022 | 66 | 0.210 |
Why?
|
| Insecta | 1 | 2024 | 46 | 0.210 |
Why?
|
| Microsatellite Repeats | 4 | 2008 | 205 | 0.210 |
Why?
|
| Ovariectomy | 1 | 2024 | 153 | 0.210 |
Why?
|
| Bone Density Conservation Agents | 1 | 2024 | 56 | 0.210 |
Why?
|
| Physical Chromosome Mapping | 1 | 2004 | 55 | 0.210 |
Why?
|
| Flow Cytometry | 2 | 2023 | 766 | 0.200 |
Why?
|
| NF-kappa B | 1 | 2026 | 441 | 0.200 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 1824 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2026 | 299 | 0.200 |
Why?
|
| Female | 24 | 2025 | 70399 | 0.200 |
Why?
|
| Mammary Arteries | 1 | 2023 | 31 | 0.190 |
Why?
|
| Cell-Derived Microparticles | 1 | 2023 | 26 | 0.190 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2900 | 0.190 |
Why?
|
| Sulfites | 3 | 2018 | 26 | 0.190 |
Why?
|
| User-Computer Interface | 3 | 2025 | 164 | 0.190 |
Why?
|
| Publications | 1 | 2022 | 36 | 0.190 |
Why?
|
| Exosomes | 1 | 2023 | 61 | 0.180 |
Why?
|
| Homologous Recombination | 2 | 2013 | 97 | 0.180 |
Why?
|
| Databases, Factual | 4 | 2023 | 1223 | 0.180 |
Why?
|
| Germ Cells | 2 | 2014 | 199 | 0.180 |
Why?
|
| Quantitative Trait Loci | 1 | 2023 | 307 | 0.170 |
Why?
|
| Cerebellum | 1 | 2025 | 440 | 0.170 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2022 | 88 | 0.170 |
Why?
|
| Sex Differentiation | 1 | 2021 | 18 | 0.170 |
Why?
|
| Computer Graphics | 1 | 2021 | 39 | 0.170 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 2337 | 0.170 |
Why?
|
| Phenotype | 5 | 2023 | 4473 | 0.160 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 422 | 0.160 |
Why?
|
| Synteny | 4 | 2015 | 66 | 0.160 |
Why?
|
| Pan troglodytes | 5 | 2007 | 68 | 0.160 |
Why?
|
| Registries | 2 | 2025 | 1617 | 0.160 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 92 | 0.160 |
Why?
|
| Mice | 14 | 2026 | 18221 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1993 | 330 | 0.160 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 111 | 0.160 |
Why?
|
| Cell Line | 2 | 2023 | 2557 | 0.160 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2012 | 568 | 0.160 |
Why?
|
| Escherichia coli | 2 | 2016 | 991 | 0.160 |
Why?
|
| Gastrointestinal Tract | 2 | 2012 | 209 | 0.150 |
Why?
|
| Aspirin | 1 | 2021 | 214 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2015 | 396 | 0.150 |
Why?
|
| Cellular Senescence | 1 | 2021 | 217 | 0.150 |
Why?
|
| Vaccinium myrtillus | 1 | 2019 | 1 | 0.150 |
Why?
|
| Anthocyanins | 1 | 2019 | 4 | 0.150 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 12 | 0.150 |
Why?
|
| Coronary Artery Bypass | 1 | 2023 | 515 | 0.150 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2012 | 216 | 0.150 |
Why?
|
| Antigens, Ly | 1 | 2019 | 31 | 0.150 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2015 | 40 | 0.150 |
Why?
|
| Body Fluids | 1 | 2019 | 45 | 0.140 |
Why?
|
| Electronic Health Records | 2 | 2016 | 816 | 0.140 |
Why?
|
| Genetic Loci | 2 | 2018 | 353 | 0.140 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2019 | 36 | 0.140 |
Why?
|
| Embryonic Stem Cells | 3 | 2015 | 156 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 227 | 0.140 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 65 | 0.140 |
Why?
|
| Phylogeny | 3 | 2012 | 687 | 0.140 |
Why?
|
| Male | 19 | 2025 | 64495 | 0.140 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 108 | 0.140 |
Why?
|
| Ultraviolet Rays | 2 | 2015 | 191 | 0.140 |
Why?
|
| Adipose Tissue | 2 | 2021 | 499 | 0.130 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2019 | 84 | 0.130 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 143 | 0.130 |
Why?
|
| Polymorphism, Genetic | 4 | 2008 | 776 | 0.130 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 780 | 0.130 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 125 | 0.130 |
Why?
|
| Histone Acetyltransferases | 1 | 2018 | 226 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 425 | 0.130 |
Why?
|
| Species Specificity | 5 | 2011 | 474 | 0.130 |
Why?
|
| Search Engine | 2 | 2016 | 9 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2024 | 468 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 2089 | 0.120 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 3471 | 0.120 |
Why?
|
| Cluster Analysis | 3 | 2025 | 412 | 0.120 |
Why?
|
| Information Dissemination | 1 | 2018 | 195 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 785 | 0.120 |
Why?
|
| Gene Ontology | 1 | 2016 | 51 | 0.120 |
Why?
|
| Histones | 3 | 2015 | 542 | 0.120 |
Why?
|
| Silver | 1 | 2016 | 27 | 0.120 |
Why?
|
| Enkephalins | 1 | 2015 | 19 | 0.120 |
Why?
|
| Rats | 5 | 2019 | 3371 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1074 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 510 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 464 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2025 | 1321 | 0.120 |
Why?
|
| Binding Sites | 1 | 2018 | 1136 | 0.120 |
Why?
|
| Laboratories | 1 | 2016 | 79 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 434 | 0.120 |
Why?
|
| Biomarkers | 3 | 2021 | 3384 | 0.110 |
Why?
|
| Protons | 1 | 2015 | 94 | 0.110 |
Why?
|
| DNA, Single-Stranded | 1 | 2015 | 69 | 0.110 |
Why?
|
| Photons | 1 | 2015 | 60 | 0.110 |
Why?
|
| Nanostructures | 1 | 2015 | 66 | 0.110 |
Why?
|
| Gold | 1 | 2015 | 54 | 0.110 |
Why?
|
| Polycomb-Group Proteins | 1 | 2015 | 24 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2012 | 224 | 0.110 |
Why?
|
| Exome | 3 | 2018 | 1066 | 0.110 |
Why?
|
| Liposomes | 2 | 2026 | 197 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 245 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2016 | 316 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 122 | 0.110 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 50 | 0.110 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 41 | 0.110 |
Why?
|
| Leucine | 1 | 2015 | 258 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2019 | 471 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2015 | 202 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2014 | 6 | 0.110 |
Why?
|
| Adult | 9 | 2025 | 31145 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2014 | 230 | 0.100 |
Why?
|
| Centromere | 2 | 2012 | 67 | 0.100 |
Why?
|
| Base Composition | 5 | 2013 | 66 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2026 | 1874 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2006 | 592 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2016 | 341 | 0.100 |
Why?
|
| Transcriptome | 1 | 2021 | 1113 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1993 | 252 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2019 | 759 | 0.100 |
Why?
|
| Serbia | 2 | 2025 | 2 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 3 | 2016 | 226 | 0.100 |
Why?
|
| DNA Transposable Elements | 2 | 2012 | 180 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 199 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2018 | 3362 | 0.100 |
Why?
|
| Genetic Testing | 2 | 2018 | 1103 | 0.100 |
Why?
|
| Gene Fusion | 1 | 2013 | 57 | 0.090 |
Why?
|
| Cytosine | 2 | 2010 | 56 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2013 | 748 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 352 | 0.090 |
Why?
|
| Haplotypes | 1 | 2014 | 516 | 0.090 |
Why?
|
| Peptides | 1 | 2015 | 704 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 479 | 0.090 |
Why?
|
| DNA Damage | 1 | 2015 | 512 | 0.090 |
Why?
|
| Precision Medicine | 3 | 2024 | 384 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2018 | 2423 | 0.090 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2012 | 81 | 0.090 |
Why?
|
| Biomedical Research | 2 | 2016 | 562 | 0.090 |
Why?
|
| Mixed Function Oxygenases | 1 | 2011 | 36 | 0.090 |
Why?
|
| Finches | 1 | 2011 | 6 | 0.090 |
Why?
|
| Vocalization, Animal | 1 | 2011 | 19 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 715 | 0.090 |
Why?
|
| Prosencephalon | 1 | 2011 | 40 | 0.090 |
Why?
|
| Prognosis | 2 | 2019 | 4863 | 0.080 |
Why?
|
| Auditory Cortex | 1 | 2011 | 26 | 0.080 |
Why?
|
| Knowledge Bases | 2 | 2023 | 39 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 585 | 0.080 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2011 | 50 | 0.080 |
Why?
|
| Chromosome Disorders | 1 | 2013 | 317 | 0.080 |
Why?
|
| Internet | 3 | 2025 | 421 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1456 | 0.080 |
Why?
|
| Neurons | 1 | 2020 | 2027 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 282 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2011 | 136 | 0.080 |
Why?
|
| Vagina | 1 | 2012 | 207 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2323 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2193 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 136 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 98 | 0.080 |
Why?
|
| Spermatozoa | 1 | 2012 | 254 | 0.080 |
Why?
|
| Guidelines as Topic | 3 | 2017 | 202 | 0.080 |
Why?
|
| Genetic Techniques | 2 | 2007 | 96 | 0.080 |
Why?
|
| Aged | 4 | 2025 | 20883 | 0.080 |
Why?
|
| Genetic Engineering | 1 | 2010 | 160 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 222 | 0.070 |
Why?
|
| Locus Control Region | 1 | 2008 | 7 | 0.070 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2008 | 15 | 0.070 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 10 | 0.070 |
Why?
|
| Exons | 1 | 2011 | 762 | 0.070 |
Why?
|
| Probability | 2 | 2004 | 305 | 0.070 |
Why?
|
| Callithrix | 1 | 2008 | 14 | 0.070 |
Why?
|
| Testis | 1 | 2010 | 389 | 0.070 |
Why?
|
| Microbiota | 1 | 2014 | 437 | 0.070 |
Why?
|
| Contig Mapping | 2 | 2006 | 46 | 0.070 |
Why?
|
| Trinucleotide Repeats | 1 | 2008 | 83 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 481 | 0.070 |
Why?
|
| Middle Aged | 4 | 2025 | 28393 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2011 | 395 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2011 | 1483 | 0.070 |
Why?
|
| Ovary | 1 | 2010 | 351 | 0.070 |
Why?
|
| Strongylocentrotus purpuratus | 1 | 2006 | 5 | 0.060 |
Why?
|
| Papio hamadryas | 1 | 2006 | 1 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 311 | 0.060 |
Why?
|
| Sex Factors | 2 | 2025 | 1339 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2021 | 4671 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 89 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2006 | 91 | 0.060 |
Why?
|
| Periodontal Pocket | 1 | 2025 | 5 | 0.060 |
Why?
|
| Radiography, Panoramic | 1 | 2025 | 6 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2011 | 543 | 0.060 |
Why?
|
| Sweden | 1 | 2025 | 37 | 0.060 |
Why?
|
| Alveolar Bone Loss | 1 | 2025 | 6 | 0.060 |
Why?
|
| Galectins | 1 | 2025 | 24 | 0.060 |
Why?
|
| Genetics, Population | 1 | 2006 | 177 | 0.060 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2025 | 28 | 0.060 |
Why?
|
| DNA Repair | 1 | 2008 | 571 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2025 | 2553 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 1220 | 0.050 |
Why?
|
| Chromosomes, Human | 2 | 2015 | 120 | 0.050 |
Why?
|
| Larva | 1 | 2025 | 245 | 0.050 |
Why?
|
| Anabolic Agents | 1 | 2024 | 15 | 0.050 |
Why?
|
| Ephemeroptera | 1 | 2024 | 1 | 0.050 |
Why?
|
| Aquatic Organisms | 1 | 2024 | 9 | 0.050 |
Why?
|
| Fresh Water | 1 | 2024 | 15 | 0.050 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 16 | 0.050 |
Why?
|
| Educational Status | 1 | 2025 | 276 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2012 | 742 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2024 | 69 | 0.050 |
Why?
|
| Biodiversity | 1 | 2024 | 72 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2016 | 147 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1384 | 0.050 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 273 | 0.050 |
Why?
|
| Child | 4 | 2025 | 26119 | 0.050 |
Why?
|
| Electrocoagulation | 1 | 2023 | 31 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2024 | 180 | 0.050 |
Why?
|
| Spasm | 1 | 2023 | 45 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2024 | 134 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2023 | 38 | 0.050 |
Why?
|
| Reference Standards | 2 | 2016 | 232 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2023 | 118 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 2896 | 0.050 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 344 | 0.050 |
Why?
|
| PubMed | 1 | 2022 | 21 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 2 | 1993 | 104 | 0.050 |
Why?
|
| Pregnancy | 3 | 2021 | 7418 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17529 | 0.040 |
Why?
|
| Asthma | 1 | 2010 | 921 | 0.040 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 2021 | 6 | 0.040 |
Why?
|
| Embryonic Germ Cells | 1 | 2021 | 7 | 0.040 |
Why?
|
| Dasatinib | 1 | 2021 | 50 | 0.040 |
Why?
|
| Multigene Family | 2 | 2007 | 289 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 2006 | 425 | 0.040 |
Why?
|
| Spermatogonia | 1 | 2021 | 27 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 968 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2023 | 373 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 116 | 0.040 |
Why?
|
| Adolescent | 3 | 2025 | 20733 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2381 | 0.040 |
Why?
|
| Models, Econometric | 1 | 2000 | 8 | 0.040 |
Why?
|
| Patents as Topic | 1 | 2000 | 18 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 732 | 0.040 |
Why?
|
| Teratoma | 1 | 2021 | 120 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4716 | 0.040 |
Why?
|
| Carbon Tetrachloride | 1 | 2019 | 5 | 0.040 |
Why?
|
| Ecosystem | 1 | 2019 | 90 | 0.040 |
Why?
|
| Drug Design | 1 | 2000 | 162 | 0.040 |
Why?
|
| Age Factors | 1 | 2025 | 2828 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1547 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2019 | 301 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 670 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 1211 | 0.030 |
Why?
|
| Urea | 1 | 2019 | 219 | 0.030 |
Why?
|
| Mitochondria | 1 | 2023 | 777 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 192 | 0.030 |
Why?
|
| Karyotyping | 2 | 2009 | 308 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2019 | 128 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 358 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 1213 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 538 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 612 | 0.030 |
Why?
|
| Web Browser | 1 | 2016 | 7 | 0.030 |
Why?
|
| Synchrotrons | 1 | 2016 | 2 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2025 | 14964 | 0.030 |
Why?
|
| Expressed Sequence Tags | 2 | 2006 | 77 | 0.030 |
Why?
|
| Photolysis | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2025 | 5049 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2015 | 14 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2017 | 119 | 0.030 |
Why?
|
| Genes | 2 | 2006 | 308 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 995 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2016 | 76 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 122 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 131 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 211 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 115 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 4029 | 0.030 |
Why?
|
| Mathematics | 1 | 1995 | 71 | 0.030 |
Why?
|
| Histone Code | 1 | 2015 | 46 | 0.030 |
Why?
|
| Kidney | 1 | 2021 | 1277 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2015 | 97 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 1996 | 199 | 0.030 |
Why?
|
| Gene Duplication | 2 | 2007 | 358 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 576 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1993 | 15 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2464 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 677 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 67 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 1993 | 41 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 51 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 269 | 0.020 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2013 | 52 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3406 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2015 | 341 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 959 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2012 | 18 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 451 | 0.020 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 18 | 0.020 |
Why?
|
| Chromosome Painting | 1 | 2012 | 14 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2013 | 147 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 38 | 0.020 |
Why?
|
| Primates | 1 | 1992 | 81 | 0.020 |
Why?
|
| DNA Repeat Expansion | 1 | 2012 | 38 | 0.020 |
Why?
|
| Autopsy | 1 | 2012 | 113 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 572 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 260 | 0.020 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 316 | 0.020 |
Why?
|
| Ruminococcus | 1 | 2011 | 11 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2012 | 277 | 0.020 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2011 | 11 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2012 | 93 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 118 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 502 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2012 | 198 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1573 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 91 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2398 | 0.020 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2011 | 57 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 151 | 0.020 |
Why?
|
| India | 1 | 2011 | 233 | 0.020 |
Why?
|
| Nucleotides | 1 | 2010 | 88 | 0.020 |
Why?
|
| Meiosis | 1 | 2010 | 110 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 480 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 256 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 653 | 0.020 |
Why?
|
| X Chromosome | 1 | 2010 | 326 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 12850 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13254 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 722 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2010 | 166 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 699 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 6199 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 976 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 25 | 0.020 |
Why?
|
| Alu Elements | 1 | 2009 | 66 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 617 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 37 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2011 | 315 | 0.020 |
Why?
|
| Base Pairing | 1 | 2008 | 40 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2008 | 70 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 524 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1487 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 177 | 0.020 |
Why?
|
| United States | 2 | 2016 | 11880 | 0.020 |
Why?
|
| Temperature | 1 | 2008 | 289 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2006 | 24 | 0.020 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2006 | 15 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 1082 | 0.020 |
Why?
|
| Complement Activation | 1 | 2006 | 50 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 1015 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 17 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2006 | 54 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 2006 | 70 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1587 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 224 | 0.010 |
Why?
|
| Stem Cells | 1 | 2010 | 704 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1591 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2006 | 189 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 152 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 316 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2006 | 201 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9997 | 0.010 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 39 | 0.010 |
Why?
|
| Retroelements | 1 | 2004 | 41 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2006 | 410 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 91 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2006 | 518 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 3317 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 152 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2004 | 109 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 279 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 326 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 1674 | 0.010 |
Why?
|
| Telomere | 1 | 2004 | 218 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 1008 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6793 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 1059 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4668 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 838 | 0.010 |
Why?
|